Format

Send to

Choose Destination
Drug Metab Rev. 2009;41(2):77-88. doi: 10.1080/03602530902741828.

Clinical pharmacology and pharmacogenetics of gemcitabine.

Author information

1
Department of Hematology-Oncology, National University Hospital, Singapore.

Abstract

Gemcitabine is a cytotoxic nucleoside analog, which is widely used in the treatment of malignancies. Interindividual differences in gemcitabine pharmacokinetics and pharmacodynamics have been demonstrated. Pharmacogenetic factors may account for a significant proportion of these differences. This review provides an update on the pharmacogenetics of gemcitabine and its influence on gemcitabine efficacy and toxicity.

PMID:
19514966
DOI:
10.1080/03602530902741828
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center